(NASDAQ: TIL) Instil Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.33%.
Instil Bio's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast TIL's revenue for 2029 to be $351,092,721, with the lowest TIL revenue forecast at $351,092,721, and the highest TIL revenue forecast at $351,092,721. On average, 1 Wall Street analysts forecast TIL's revenue for 2030 to be $1,013,470,251, with the lowest TIL revenue forecast at $1,013,470,251, and the highest TIL revenue forecast at $1,013,470,251.
In 2031, TIL is forecast to generate $1,810,933,643 in revenue, with the lowest revenue forecast at $1,810,933,643 and the highest revenue forecast at $1,810,933,643.